We provide end-to-end host-defense testing, spanning cell sourcing and compound formulation to deep epigenetic sequencing and data analysis, delivering a unified, seamless research workflow for your preclinical projects.
Creative Biolabs provides an advanced, physiologically relevant platform for mapping viral host-pathogen interactions and profiling interferon signaling cascades. Our service delivers a detailed suite of analytical assays - ranging from ultra-sensitive multiplex cytokine quantification to high-resolution epigenetic and transcriptomic mapping in primary human cell co-cultures. By partnering with us, our clients gain robust, research-ready datasets that clarify target engagement, identify potential off-target inflammatory responses, and elucidate detailed mechanisms of action. This thorough biological insight enables drug discovery teams to confidently select high-value leads, optimize dosing strategies, and accelerate their preclinical research pipelines.
The host defense network is governed by a delicate balance between protective interferon signaling and inflammatory tissue damage. According to published data, highly pathogenic viruses actively evade host detection by blocking transcription factor nuclear import or destabilizing messenger RNAs via host epitranscriptomic mechanisms. Creative Biolabs' profiling service deconstructs these evasion cascades, validating compound efficacy while monitoring key safeguards to prevent spontaneous autoinflammatory pathology.
Fig.1 A representative scheme of putative sceneries during the HIV-1 infection in macrophages. 1
We provide end-to-end host-defense testing, spanning cell sourcing and compound formulation to deep epigenetic sequencing and data analysis, delivering a unified, seamless research workflow for your preclinical projects.
Our team tailors every testing pipeline to your specific therapeutic modality, offering bespoke primary cell co-cultures, selectable viral strains, and targeted, custom-designed gene panels for high-resolution evaluation.
Our platform quantifies up to forty-five type I, II, and III interferons, interleukins, and chemokines concurrently, maintaining low limits of detection using micro-volume biological samples under twenty-five microliters.
Our methodologies undergo strict validation against recognized immunological standards, ensuring that every dataset delivered to your research team is highly reproducible, mathematically verified, and ready for regulatory scrutiny.
Creative Biolabs leverages over twenty years of dedicated immunology research, translating complex cellular defense mechanisms into actionable preclinical data that elevates the value and reliability of your biopharmaceutical development programs.
Our state-of-the-art systems-biology platforms capture the dynamic host-pathogen interface with exceptional molecular resolution, bypassing conventional testing limitations to provide clear, reliable biological answers for complex research projects.
We reject mutated cell cultures, opting instead to build native immune environments utilizing primary human tissues that accurately preserve the complex, uncompromised regulatory networks of normal host defense.
Our methodologies undergo strict validation against recognized immunological standards, ensuring that every dataset delivered to your research team is highly reproducible, mathematically verified, and ready for regulatory scrutiny.
Get a Quote Today to receive our complete technological assay catalog or to schedule a technical consultation.
Why are primary cell models preferred over immortalized cell lines for interferon profiling?
Primary human cells are preferred because immortalized lines frequently possess genetic defects in their signaling cascades, such as deletions in interferon genes. Utilizing primary cells preserves intact, native immune pathways to prevent misleading false results.
How does Creative Biolabs differentiate between protective antiviral activation and dangerous cytokine storm risks?
We trace multi-analyte kinetics over seventy-two hours. Protective responses show rapid, self-limiting peaks of early interferons. In contrast, immunopathology profiles exhibit delayed, non-resolving transcription of highly toxic cytokines like interleukin-six and tumor necrosis factor.
This platform maps macrophage functional plasticity by tracking primary cell transition between classical M1 and alternative M2 states. Under customizable stimulation regimens, we quantify metabolic flux, cell-surface markers, and secretome signatures.
Learn More →This service constructs three-dimensional in vitro cell aggregates to model macrophage-lymphocyte crosstalk in persistent inflammatory structures, helping developers analyze chemokine recruitment and test candidates targeting chronic intracellular containment.
Learn More →Creative Biolabs offers biopharmaceutical developers an integrated, high-resolution platform to map cellular defense cascades, trace epigenetic trained immunity signatures, detect inflammatory pyroptosis, and de-risk immunological checkpoints. By utilizing physiologically accurate primary human co-cultures and state-of-the-art bioinformatic pathway modeling, we deliver the precise, research-ready data package required to advance your candidate from discovery into in vivo validation studies.
Contact us today to receive our complete technological assay catalog or to schedule a technical consultation.
Reference